Clinical Trial Update: Inhaled Amikacin in Preventing AECOPD [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating inhaled amikacin for preventing acute exacerbations in chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• amikacin (inhaled formulation) (amikacin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: COPD, COPD Exacerbation | Phase 3 | Status: UNKNOWN